Litcius/Paper detail

Von Willebrand factor and ADAMTS13 activity as clinical severity markers in patients with COVID-19

A. Marco, Pascual Marco

2021Journal of Thrombosis and Thrombolysis37 citationsDOIOpen Access PDF

Topics & Concepts

ADAMTS13MedicineVon Willebrand factorInternal medicineFibrinogenIntensive care unitCoronavirus disease 2019 (COVID-19)Severity of illnessClinical significanceImmunologyGastroenterologyDiseasePlateletInfectious disease (medical specialty)COVID-19 Clinical Research StudiesComplement system in diseasesLong-Term Effects of COVID-19
Von Willebrand factor and ADAMTS13 activity as clinical severity markers in patients with COVID-19 | Litcius